1. Home
  2. ARWR vs CMC Comparison

ARWR vs CMC Comparison

Compare ARWR & CMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • CMC
  • Stock Information
  • Founded
  • ARWR 2003
  • CMC 1915
  • Country
  • ARWR United States
  • CMC United States
  • Employees
  • ARWR N/A
  • CMC N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • CMC Steel/Iron Ore
  • Sector
  • ARWR Health Care
  • CMC Industrials
  • Exchange
  • ARWR Nasdaq
  • CMC Nasdaq
  • Market Cap
  • ARWR 5.9B
  • CMC 6.4B
  • IPO Year
  • ARWR 1993
  • CMC 1987
  • Fundamental
  • Price
  • ARWR $40.96
  • CMC $59.40
  • Analyst Decision
  • ARWR Strong Buy
  • CMC Buy
  • Analyst Count
  • ARWR 8
  • CMC 11
  • Target Price
  • ARWR $47.75
  • CMC $63.91
  • AVG Volume (30 Days)
  • ARWR 1.7M
  • CMC 1.5M
  • Earning Date
  • ARWR 11-25-2025
  • CMC 10-16-2025
  • Dividend Yield
  • ARWR N/A
  • CMC 1.21%
  • EPS Growth
  • ARWR N/A
  • CMC N/A
  • EPS
  • ARWR N/A
  • CMC 0.74
  • Revenue
  • ARWR $572,976,000.00
  • CMC $7,798,480,000.00
  • Revenue This Year
  • ARWR $21,287.22
  • CMC $11.56
  • Revenue Next Year
  • ARWR N/A
  • CMC $5.86
  • P/E Ratio
  • ARWR N/A
  • CMC $80.27
  • Revenue Growth
  • ARWR 2816.20
  • CMC N/A
  • 52 Week Low
  • ARWR $9.57
  • CMC $37.92
  • 52 Week High
  • ARWR $43.69
  • CMC $64.53
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 60.87
  • CMC 52.45
  • Support Level
  • ARWR $37.35
  • CMC $55.97
  • Resistance Level
  • ARWR $42.00
  • CMC $58.83
  • Average True Range (ATR)
  • ARWR 2.18
  • CMC 1.55
  • MACD
  • ARWR -0.28
  • CMC -0.12
  • Stochastic Oscillator
  • ARWR 61.35
  • CMC 54.60

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About CMC Commercial Metals Company

Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group.

Share on Social Networks: